A Double-Blind, Placebo-Controlled, Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease.
Phase of Trial: Phase III
Latest Information Update: 15 Jul 2011
At a glance
- Drugs Rabeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 02 Feb 2010 Actual end date (Oct 2005) added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Planned number of patients (300) added as reported by ClinicalTrials.gov.
- 31 Jul 2007 Status changed from in progress to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History